Swedish pharmaceutical contract development and manufacturing organization (CDMO) Recipharm has signed two separate agreements to acquire Kemwell’s pharmaceutical CDMO businesses.
Kemwell has integrated facilities in India, Sweden and the US and a portfolio of services for sterile and non-sterile products from preformulation to commercial supply worldwide. It offers expertise in inhaled, nasal, oral, parenteral and topical dosage forms.